RICHARD MORO: Open Payments
NPI 1700859006 · PLAINFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,109 in 234 payments from 30 companies in 2025. Trend: 2023 $4,736 · 2024 $5,497 · 2025 $4,109
Food & beverage: $4,027Education: $82
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $505 |
| Phathom Pharmaceuticals, Inc. | 27 | $434 |
| ABBVIE INC. | 40 | $395 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $254 |
| Novo Nordisk Inc | 13 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $197 |
| Viatris Specialty LLC | 6 | $194 |
| Regeneron Healthcare Solutions, Inc. | 4 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $179 |
| Axsome Therapeutics, Inc. | 10 | $175 |
Products named: VOQUEZNA, TRINTELLIX, Kerendia, YUPELRI, FARXIGA, VRAYLAR, DUPIXENT, CAPLYTA.
Industry payments across CT — which companies pay providers there.
